Lazarou, C.; Moysidou, E.; Christodoulou, M.; Lioulios, G.; Sampani, E.; Dimitriadis, C.; Fylaktou, A.; Stangou, M.
Non-Invasive Biomarkers for Early Diagnosis of Kidney Allograft Dysfunction: Current and Future Applications in the Era of Precision Medicine. Medicina 2025, 61, 262.
https://doi.org/10.3390/medicina61020262
AMA Style
Lazarou C, Moysidou E, Christodoulou M, Lioulios G, Sampani E, Dimitriadis C, Fylaktou A, Stangou M.
Non-Invasive Biomarkers for Early Diagnosis of Kidney Allograft Dysfunction: Current and Future Applications in the Era of Precision Medicine. Medicina. 2025; 61(2):262.
https://doi.org/10.3390/medicina61020262
Chicago/Turabian Style
Lazarou, Christina, Eleni Moysidou, Michalis Christodoulou, Georgios Lioulios, Erasmia Sampani, Chrysostomos Dimitriadis, Asimina Fylaktou, and Maria Stangou.
2025. "Non-Invasive Biomarkers for Early Diagnosis of Kidney Allograft Dysfunction: Current and Future Applications in the Era of Precision Medicine" Medicina 61, no. 2: 262.
https://doi.org/10.3390/medicina61020262
APA Style
Lazarou, C., Moysidou, E., Christodoulou, M., Lioulios, G., Sampani, E., Dimitriadis, C., Fylaktou, A., & Stangou, M.
(2025). Non-Invasive Biomarkers for Early Diagnosis of Kidney Allograft Dysfunction: Current and Future Applications in the Era of Precision Medicine. Medicina, 61(2), 262.
https://doi.org/10.3390/medicina61020262
